Umeda, Y., Morikawa, M., Anzai, M., Ameshima, S., Kadowaki, M., Waseda, Y., . . . Ishizuka, T. Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationUmeda, Yukihiro, et al. Predictive Value of Integrated 18F-FDG PET/MRI in the Early Response to Nivolumab in Patients with Previously Treated Non-small Cell Lung Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationUmeda, Yukihiro, et al. Predictive Value of Integrated 18F-FDG PET/MRI in the Early Response to Nivolumab in Patients with Previously Treated Non-small Cell Lung Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.